Corticosteroids. Mechanisms of Action in Health and Disease

Rheumatic Disease Clinics of North America

Volumn 42, Issue 1, 2016, Pages 15-31

  Ramamoorthy, Sivapriya ^a   Cidlowski, John A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Glucocorticoid; Glucocorticoid receptor; Glucocorticoid signaling; Hypothalamic pituitary adrenal axis; Isoforms; Phosphorylation; Polymorphism

Indexed keywords

CORTICOSTERONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; CORTICOSTEROID; ISOPROTEIN;

AUTOIMMUNE DISEASE; BIOAVAILABILITY; CATARACT; CELL SPECIFICITY; CIRCADIAN RHYTHM; CORTICOSTEROID RELEASE; DIABETES MELLITUS; DRUG EFFICACY; DRUG MEGADOSE; DRUG RECEPTOR BINDING; DRUG RESPONSE; DRUG SAFETY; DRUG SENSITIVITY; ELECTROLYTE DISTURBANCE; ENDOCRINE DISEASE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOME ANALYSIS; HEMATOLOGIC MALIGNANCY; HORMONE ACTION; HUMAN; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM DYSFUNCTION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFLAMMATION; METABOLIC SYNDROME X; MUSCLE ATROPHY; NONHUMAN; OSTEOPOROSIS; PEPTIC ULCER; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SECRETION; REVIEW; RISK BENEFIT ANALYSIS; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SKIN ATROPHY; SPLICING DEFECT; STEROIDOGENESIS; TISSUE SPECIFICITY; TREATMENT PLANNING; WOUND HEALING IMPAIRMENT; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HYPOPHYSIS ADRENAL SYSTEM; METABOLISM;

ADRENAL CORTEX HORMONES; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION;

EID: 84961256311     PISSN: 0889857X     EISSN: 15583163     Source Type: Journal    
DOI: 10.1016/j.rdc.2015.08.002     Document Type: Review

References (87)

1. Van Staa T.P., Leufkens H.G., Abenhaim L., et al. Use of oral corticosteroids in the United Kingdom. QJM 2000, 93:105-111.
2. Rhen T., Cidlowski J.A. Antiinflammatory action of glucocorticoids: new mechanisms for old drugs. N Engl J Med 2005, 353:1711-1723.
3. Schacke H., Docke W.D., Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 2002, 96:23-24.
4. Barnes P.J. Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol 2010, 120:76-85.
5. Miller W.L., Auchus R.J. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 2011, 32:81-151.
6. Webster J.I., Tonelli L., Sternberg E.M. Neuroendocrine regulation of immunity. Annu Rev Immunol 2002, 20:125-163.
7. John C.D., Buckingham J.C. Cytokines: regulation of the hypothalamo-pituitary-adrenocortical axis. Curr Opin Pharmacol 2003, 3:78-84.
8. Walker J.J., Spiga F., Gupta R., et al. Rapid intra-adrenal feedback regulation of glucocorticoid synthesis. J R Soc Interface 2015, 12:20140875.
9. Breuner C.W., Orchinik M. Plasma binding proteins as mediators of corticosteroid action invertebrates. J Endocrinol 2002, 175:99-112.
10. Seckl J.R. 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action. Curr Opin Pharmacol 2004, 4:597-602.
11. Cooper M.S., Stewart P.M. 11Beta-hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation. J Clin Endocrinol Metab 2009, 94:4645-4654.
12. Kumar R., Thompson E.B. Gene regulation by the glucocorticoid receptor: structure:function relationship. J Steroid Biochem Mol Biol 2005, 94:383-394.
13. Bledsoe R.K., Montana V.G., Stanley T.B., et al. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 2002, 110:93-105.
14. Grad I., Picard D. The glucocorticoid responses are shaped by molecular chaperones. Mol Cell Endocrinol 2007, 275:2-12.
15. Pratt W.B., Toft D.O. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 1997, 18:306-360.
16. Beato M. Gene regulation by steroid hormones. Cell 1989, 56:335-344.
17. Freedman L.P. Anatomy of the steroid receptor zinc finger region. Endocr Rev 1992, 13:129-145.
18. Surjit M., Ganti K.P., Mukherji A., et al. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 2011, 145:224-241.
19. Hudson W.H., Youn C., Ortlund E.A. The structural basis of direct glucocorticoid- mediated transrepression. Nat Struct Mol Biol 2013, 20:53-58.
20. John S., Sabo P.J., Thurman R.E., et al. Chromatin accessibility predetermines glucocorticoid receptor binding patterns. Nat Genet 2011, 43:264-268.
21. Burd C.J., Archer T.K. Chromatin architecture defines the glucocorticoid response. Mol Cell Endocrinol 2013, 380(1-2):25-31.
22. Reddy T.E., Pauli F., Sprouse R.O., et al. Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Res 2009, 19:2163-2171.
23. Oakley R.H., Revollo J., Cidlowski J.A. Glucocorticoids regulate arrestin gene expression and redirect the signaling profile of G protein-coupled receptors. Proc Natl Acad Sci U S A 2012, 109:17591-17596.
24. Ramamoorthy S., Cidlowski J.A. Ligand-induced repression of the glucocorticoid receptor gene is mediated by an NCoR1 repression complex formed by long-range chromatin interactions with intragenic glucocorticoid response elements. Mol Cell Biol 2013, 33:1711-1722.
25. Uhlenhaut N.H., Barish G.D., Yu R.T., et al. Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes. Mol Cell 2013, 49:158-171.
26. Rogatsky I., Ivashkiv L.B. Glucocorticoid modulation of cytokine signaling. Tissue Antigens 2006, 68:1-12.
27. Nissen R.M., Yamamoto K.R. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev 2000, 14:2314-2329.
28. Yang-Yen H.F., Chambard J.C., Sun Y.L., et al. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 1990, 62:1205-1215.
29. Lamberts S.W., Huizenga A.T., de Lange P., et al. Clinical aspects of glucocorticoid sensitivity. Steroids 1996, 61:157-160.
30. Reddy T.E., Gertz J., Crawford G.E., et al. The hypersensitive glucocorticoid response specifically regulates period 1 and expression of circadian genes. Mol Cell Biol 2012, 32:3756-3767.
31. Jenkins B.D., Pullen C.B., Darimont B.D. Novel glucocorticoid receptor coactivator effector mechanisms. Trends Endocrinol Metab 2001, 12:122-126.
32. Lonard D.M., O'Malley B.W. Expanding functional diversity of the coactivators. Trends Biochem Sci 2005, 30:126-132.
33. Rosenfeld M.G., Glass C.K. Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem 2001, 276:36865-36868.
34. Meijsing S.H., Pufall M.A., So A.Y., et al. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 2009, 324:407-410.
35. Ronacher K., Hadley K., Avenant C., et al. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction. Mol Cell Endocrinol 2009, 299:219-231.
36. Groeneweg F.L., Karst H., de Kloet E.R., et al. Mineralocorticoid and glucocorticoid receptors at the neuronal membrane, regulators of nongenomic corticosteroid signaling. Mol Cell Endocrinol 2012, 350:299-309.
37. Samarasinghe R.A., Witchell S.F., DeFranco D.B. Cooperativity and complemenarity: synergies in non-classical and classical glucocorticoid signaling. Cell Cycle 2012, 11:2819-2827.
38. Croxtall J.D., Choudhury Q., Flower R.J. Glucocorticoids act within minutes to inhibit recruitment of signaling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism. Br J Pharmacol 2000, 130:289-298.
39. Solito E., Mulla A., Morris J.F., et al. Dexamethasone induces rapid serine-phosphorylation and membrane translocation of annexin 1 in a human folliculostellate cell line via a novel nongenomic mechanism involving the glucocorticoid receptor, protein kinase C, phosphatidylinositol 3-kinase, and mitogen-activated protein kinase. Endocrinology 2003, 144:1164-1174.
40. Boldizsar F., Talaber G., Szabo M., et al. Emerging pathways of non-genomic glucocorticoid (GC) signalling in T cells. Immunobiology 2010, 215:521-526.
41. Matthews L., Berry A., Ohanian V., et al. Caveolin mediates rapid glucocorticoid effects and couples glucocorticoid action to the antiproliferative program. Mol Endocrinol 2008, 22:1320-1330.
42. Samarasinghe R.A., Di Maio R., Volonte D., et al. Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation. Proc Natl Acad Sci U S A 2011, 108:16657-16662.
43. Bamberger C.M., Bamberger A.M., de Castro M., et al. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 1995, 95:2435-2441.
44. Oakley R.H., Sar M., Cidlowski J.A. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J Biol Chem 1996, 271:9550-9559.
45. Kino T., Su Y.A., Chrousos G.P. Human glucocorticoid receptor isoform beta: recent understanding of its potential implications in physiology and pathophysiology. Cell Mol Life Sci 2009, 66:3435-3448.
46. Lewis-Tuffin L.J., Cidlowski J.A. The physiology of human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance. Ann N Y Acad Sci 2006, 1069:1-9.
47. Kelly A., Bowen H., Jee Y.K., et al. The glucocorticoid receptor beta isoform can mediate transcriptional repression by recruiting histone deacetylases. J Allergy Clin Immunol 2008, 121:203-208.e1.
48. Kim S.H., Kim D.H., Lavender P., et al. Repression of TNF-alpha-induced IL-8 expression by the glucocorticoid receptor-beta involves inhibition of histone H4 acetylation. Exp Mol Med 2009, 41:297-306.
49. Lewis-Tuffin L.J., Jewell C.M., Bienstock R.J., et al. The Human glucocorticoid receptor b (hGRb) binds RU-486 and is transcriptionally active. Mol Cell Biol 2007, 27:2266-2282.
50. Hauk P.J., Hamid Q.A., Chrousos G.P., et al. Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J Allergy Clin Immunol 2000, 105:782-787.
51. Jain A., Wordinger R.J., Yorio T., et al. Spliceosome protein (SRp) regulation of glucocorticoid receptor isoforms and glucocorticoid response in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 2012, 53:857-866.
52. Zhu J., Gong J.Y., Goodman O.B., et al. Bombesin attenuates pre-mRNA splicing of glucocorticoid receptor by regulating the expression of serine-arginine protein p30c (SRp30c) in prostate cancer cells. Biochim Biophys Acta 2007, 1773:1087-1094.
53. DuBois D.C., Sukumaran S., Jusko W.J., et al. Evidence for a glucocorticoid receptor beta splice variant in the rat and its physiological regulation in liver. Steroids 2013, 78:312-320.
54. Hinds T.D., Ramakrishnan S., Cash H.A., et al. Discovery of glucocorticoid receptor-beta in mice with a role in metabolism. Mol Endocrinol 2010, 24:1715-1727.
55. Schaaf M.J., Champagne D., van Laanen I.H., et al. Discovery of a functional glucocorticoid receptor beta-isoform in zebrafish. Endocrinology 2008, 149:1591-1599.
56. Ray D.W., Davis J.R., White A., et al. Glucocorticoid receptor structure and function in glucocorticoid-resistant small cell lung carcinoma cells. Cancer Res 1996, 56:3276-3280.
57. Beger C., Gerdes K., Lauten M., et al. Expression and structural analysis of glucocorticoid receptor isoform gamma in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approach. Br J Haematol 2003, 122:245-252.
58. Rivers C., Levy A., Hancock J., et al. Insertion of an amino acid in the DNA-binding domain of the glucocorticoid receptor as a result of alternative splicing. J Clin Endocrinol Metab 1999, 84:4283-4286.
59. de Lange P., Segeren C.M., Koper J.W., et al. Expression in hematological malignancies of a glucocorticoid receptor splice variant that augments glucocorticoid receptor-mediated effects in transfected cells. Cancer Res 2001, 61:3937-3941.
60. Gaitan D., DeBold C.R., Turney M.K., et al. Glucocorticoid receptor structure and function in an adrenocorticotropin-secreting small cell lung cancer. Mol Endocrinol 1995, 9:1193-1201.
61. Krett N.L., Pillay S., Moalli P.A., et al. A variant glucocorticoid receptor messenger RNA is expressed in multiple myeloma patients. Cancer Res 1995, 55:2727-2729.
62. Lu N.Z., Cidlowski J.A. Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol Cell 2005, 18:331-342.
63. Oakley R.H., Cidlowski J.A. Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J Biol Chem 2011, 286:3177-3184.
64. Lu N.Z., Collins J.B., Grissom S.F., et al. Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor. Mol Cell Biol 2007, 27:7143-7160.
65. Wu I., Shin S.C., Cao Y., et al. Selective glucocorticoid receptor translational isoforms reveal glucocorticoid-induced apoptotic transcriptomes. Cell Death Dis 2013, 4:e453.
66. Gross K.L., Oakley R.H., Scoltock A.B., et al. Glucocorticoid receptor a isoform-selective regulation of antiapoptotic genes in osteosarcoma cells: a new mechanism for glucocorticoid resistance. Mol Endocrinol 2011, 25:1087-1099.
67. Bender I.K., Cao Y., Lu N.Z. Determinants of the heightened activity of glucocorticoid receptor translational isoforms. Mol Endocrinol 2013, 27:1577-1587.
68. Cao Y., Bender I.K., Konstantinidis A.K., et al. Glucocorticoid receptor translational isoforms underlie maturational stage-specific glucocorticoid sensitivities of dendritic cells in mice and humans. Blood 2013, 121:1553-1562.
69. Sinclair D., Webster M.J., Wong J., et al. Dynamic molecular and anatomical changes in the glucocorticoid receptor in human cortical development. Mol Psychiatry 2011, 16:504-515.
70. Sinclair D., Webster M.J., Fullerton J.M., et al. Glucocorticoid receptor mRNA and protein isoform alterations in the orbitofrontal cortex in schizophrenia and bipolar disorder. BMC Psychiatry 2012, 12:84.
71. Beck I.M., Vanden Berghe W., Vermeulen L., et al. Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. Endocr Rev 2009, 30:830-882.
72. Wang Z., Frederick J., Garabedian M.J. Deciphering the phosphorylation ''code'' of the glucocorticoid receptor in vivo. J Biol Chem 2002, 277:26573-26580.
73. Avenant C., Ronacher K., Stubsrud E., et al. Role of ligand-dependent GR phosphorylation and half-life in determination of ligand-specific transcriptional activity. Mol Cell Endocrinol 2010, 327:72-88.
74. Galliher-Beckley A.J., Williams J.G., Collins J.B., et al. Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles. Mol Cell Biol 2008, 28:7309-7322.
75. Galliher-Beckley A.J., Williams J.G., Cidlowski J.A. Ligand-independent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling. Mol Cell Biol 2011, 31:4663-4675.
76. Webster J.C., Jewell C.M., Bodwell J.E., et al. Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein. J Biol Chem 1997, 272:9287-9293.
77. Chen W., Dang T., Blind R.D., et al. Glucocorticoid receptor phosphorylation differentially affects target gene expression. Mol Endocrinol 2008, 22:1754-1766.
78. Deroo B.J., Rentsch C., Sampath S., et al. Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking. Mol Cell Biol 2002, 22:4113-4123.
79. Wallace A.D., Cidlowski J.A. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J Biol Chem 2001, 276:42714-42721.
80. Wang X., DeFranco D.B. Alternative effects of the ubiquitin-proteasome mediated by CHIP, an E3 ligase. Mol Endocrinol 2005, 19:1474-1482.
81. Le Drean Y., Mincheneau N., Le Goff P., et al. Potentiation of glucocorticoid receptor transcriptional activity by sumoylation. Endocrinology 2002, 143:3482-3489.
82. Ito K., Yamamura S., Essilfie-Quaye S., et al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med 2006, 203:7-13.
83. Charmandari E., Chrousos G.P., Lambrou G.I., et al. Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man. PLoS One 2011, 6:e25612.
84. Jewell C.M., Cidlowski J.A. Molecular evidence for a link between the N363S glucocorticoid receptor polymorphism and altered gene expression. J Clin Endocrinol Metab 2007, 92:3268-3277.
85. van Rossum E.F., Lamberts S.W. Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog Horm Res 2004, 59:333-357.
86. Derijk R.H., Schaaf M.J., Turner G., et al. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis. J Rheumatol 2001, 28:2383-2388.
87. Clark A.R., Belvisi M.G. Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor. Pharmacol Ther 2012, 134:54-67.